CureLab Oncology Revenue and Competitors
Estimated Revenue & Valuation
- CureLab Oncology's estimated annual revenue is currently $1M per year.
- CureLab Oncology's estimated revenue per employee is $77,500
Employee Data
- CureLab Oncology has 13 Employees.
- CureLab Oncology grew their employee count by 0% last year.
CureLab Oncology's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder and CEO | Reveal Email/Phone |
2 | COO | Reveal Email/Phone |
3 | VP Research and Development | Reveal Email/Phone |
4 | Interim Clinical Director | Reveal Email/Phone |
5 | Director Basic Research | Reveal Email/Phone |
6 | Director Business Development | Reveal Email/Phone |
7 | Director Business Development | Reveal Email/Phone |
CureLab Oncology Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is CureLab Oncology?
CureLab Oncology is a biotechnology company developing new anti-cancer biologics. CureLab Oncology is committed to creating a family of revolutionary therapies for oncology patients in order to help prolong their lives. CureLab Oncology's lead product, Elenagen™, is a plasmid (supercoiled circular DNA) encoding gene p62/SQSTM1. Elenagen™ reverses tumor grade, changes tumor microenvironment, enhances the anti-cancer effects of other therapies (e.g. chemotherapy), mitigates chronic inflammation, and stimulates an immune attack on the tumor. The CureLab Oncology team has completed its international Phase I/IIa Clinical Trials of Elenagen™. The vaccine demonstrated a high degree of safety as well as clinical benefits in a number of patients. Based on these successful results, we initiated Phase II Clinical Trials outside of the United States, and are now preparing Phase II Clinical Trials within the US.
keywords:N/A
N/A
Total Funding
13
Number of Employees
$1M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Boston
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.8M | 13 | -19% | $3M |
#2 | $2.1M | 13 | N/A | N/A |
#3 | $0.4M | 13 | -7% | $71.8M |
#4 | $1.3M | 13 | -46% | $96.5M |
#5 | $1M | 13 | -50% | $200M |